Please login to the form below

Not currently logged in
Email:
Password:

Hywel Day joins Napp Pharmaceuticals

Moves from Mundipharma to take up managing director role

Napp Pharmaceuticals Hywel DayNapp Pharmaceuticals has appointed Hywel Day as its new managing director.

It’s a return to Napp for Day, who spent 10 years at Napp from 2003, before moving to Mundipharma.

At that company he served in a general manager role, based in The Netherlands, where he led the business through a substantial transformation, which involved a significant cultural shift and a diversification of the business portfolio.

Day said: “To be given the opportunity to lead a top UK pharmaceutical company is incredibly exciting. Not only is Napp a company with a long heritage of providing innovative, high-quality medicines to patients, but it is also a great place to work.

“I’m looking forward to working with a great bunch of intelligent, diligent and fun people - together, we will continue to nurture Napp’s values of striving for excellence and delivering on our promises to the NHS, patients, our business partners and each other.”

9th March 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics